Literature DB >> 4860352

Explanatory and pragmatic attitudes in therapeutical trials.

D Schwartz, J Lellouch.   

Abstract

Mesh：

Year:  1967        PMID： 4860352     DOI： 10.1016/0021-9681(67)90041-0

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN： 0021-9681


× No keyword cloud information.
  295 in total

Review 1.  Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

Authors:  C Bombardier; A Maetzel
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Designing trials of interventions to change professional practice in primary care: lessons from an exploratory study of two change strategies.

Authors:  S Rogers; C Humphrey; I Nazareth; S Lister; Z Tomlin; A Haines
Journal:  BMJ       Date:  2000-06-10

Review 3.  Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies.

Authors:  D A Revicki; L Frank
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

Review 4.  Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.

Authors:  M Sculpher; E Fenwick; K Claxton
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

5.  For and against: clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial.

Authors:  C Weijer; S H Shapiro; K Cranley Glass
Journal:  BMJ       Date:  2000-09-23

6.  The problem of protocol driven costs in pharmacoeconomic analysis.

Authors:  D Coyle; K M Lee
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

Review 7.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  S Byford; S Palmer
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

8.  Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.

Authors:  C H van Jaarsveld; J W Jacobs; M J van der Veen; A A Blaauw; A A Kruize; D M Hofman; H L Brus; G A van Albada-Kuipers; A H Heurkens; E J ter Borg; H C Haanen; C van Booma-Frankfort; Y Schenk; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

9.  Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality.

Authors:  Xiaoye Zhu; Pim J van Leeuwen; Erik Holmberg; Meelan Bul; Sigrid Carlsson; Fritz H Schröder; Monique J Roobol; Jonas Hugosson
Journal:  J Med Screen       Date:  2012-09       Impact factor: 2.136

10.  Effect of a training programme to reduce stress in carers of patients with dementia.

Authors:  H Brodaty; M Gresham
Journal:  BMJ       Date:  1989-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.